Bio-Techne

Local Coverage Determinations Roundup: Opko Health, Bio-Techne, LynxDx, MDxHealth

Bio-Techne, Nonagen Bioscience Ink Agreement to Manufacture Multiplex Bladder Cancer Panel

Bio-Techne Fiscal Q3 Revenues Rise 19 Percent

360Dx Top 30 Remains Essentially Flat in February

Bio-Techne, Thermo Fisher Scientific to Further Develop, Commercialize Kidney Transplant Rejection Assay

Bio-Techne Fiscal Q2 Revenues Rise 20 Percent

JP Morgan Healthcare Conference Day 3: Quest Diagnostics, Exact Sciences, Quidel, More

360Dx Index Rises 20 Percent in 2021

Bio-Techne Fiscal Q1 Revenues Rise 26 Percent

Broader Markets Lift 360Dx Index 3 Percent in October

Bio-Techne Q4 Revenues Jump 47 Percent

Bio-Techne, Indian Eye Hospital Collaborate On Diagnostic Test for Ophthalmic Disorders

Bio-Techne Fiscal Q3 Revenues Rise 25 Percent as End Markets Improve

In Brief This Week: Bio-Techne, Mologic, Caris Life Sciences, And More

Bio-Techne Obtains CE Mark for Exosomal Liquid Biopsy Prostate Test

In Brief This Week: Grail, Illumina, Veracyte, Aspira Women's Health, and More

Bio-Techne to Acquire Molecular Diagnostics Firm Asuragen for up to $320M

Bio-Techne Obtains Reimbursement Contract With Humana for Exosome Diagnostics Prostate Biopsy Test